ob0004oc3 | Oral Communications | OU2024
Vincent Royce
, Panunzi Simona
, Mare Tracey
, Luxton James
, le Roux Carel
, Angelini Giulia
, Garcovich Matteo
, Riccardi Laura
, Pompili Maurizio
, Mingrone Geltrude
Background: Approximately 15-25% of the world population has non-alcoholic fatty liver disease (NAFLD) and nearly quarter go on to develop non-alcoholic steatohepatitis (NASH). Obesity and T2DM are strong risk factors with prevalence of NAFLD rising to 90% in obesity and 60% in T2DM. Liver biopsy remains the gold standard in diagnosis and prognosis; nevertheless, it is expensive and invasive. The underlying fibrosis stage is key in determining clinical outcome...